Arcturus therapeutics to attend upcoming investor conferences

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global late-stage clinical messenger rna medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the company will participate in the following investor conferences: citi's 18th annual biopharma conference 2023 (hosting 1x1 meetings) wednesday, september 6 – 7, 2023 2023 wells fargo heal.
ARCT Ratings Summary
ARCT Quant Ranking